EAGLE PHARMACEUTICALS, INC. 4
4 · EAGLE PHARMACEUTICALS, INC. · Filed May 15, 2017
Insider Transaction Report
Form 4
Meyers Peter A.
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2017-05-15+50,000→ 50,000 totalExercise: $82.30Exp: 2027-05-14→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option vests over a period of four years, with 25% of the shares underlying the option vesting on May 15, 2018, the first anniversary of the date of grant, and the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.